Nigeria received million doses of the AstraZeneca/Oxford vaccine, manufactured by the Serum Institute of India (SII). The AstraZeneca/Oxford vaccine is cheap – costs less than two bottles of beer – easy to make and store, and it's known to be the most suitable for developing countries like Nigeria. The vaccine arrived the Nnamdi Azikiwe International Airport, Abuja, through a joint effort with the CEPI, Gavi, UNICEF and WHO. The delivery, which came from Mumbai to Abuja, is part of a first of supplies, which will continue in coming days and weeks. The COVAX Facility is expected to deliver
Nigeria received million doses of the AstraZeneca/Oxford vaccine, manufactured by the Serum Institute of India (SII). The AstraZeneca/Oxford vaccine is cheap – costs less than two bottles of beer – easy to make and store, and it's known to be the most suitable for developing countries like Nigeria. The vaccine arrived the Nnamdi Azikiwe International Airport, Abuja, through a joint effort with the CEPI, Gavi, UNICEF and WHO. The delivery, which came from Mumbai to Abuja, is part of a first of supplies, which will continue in coming days and weeks. The COVAX Facility is expected to deliver around 90 million doses of COVID-19 vaccines to the African Region in the first quarter of 2021 and has committed to providing up to 600 million doses to the region by end-2021 to cover 20 per cent of the population.
Size: 5184px × 3456px
Location: Nigeria
Photo credit: © Immanuel Afolabi / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: abuja, africa, african, airport, astrazeneca/oxford, azikiwe, black, cepi, coronavirus, countries, covax, covid-19, gavi, india, institute, international, lives, matter, mumbai, nigeria, nnamdi, pandemic, people, population, region, serum, unicef, vaccination, vaccine, vaccines
